Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vladimir Potkin"'
Autor:
Vladimir Potkin, Aliaxandr Pushkarchuk, Alexandra Zamaro, Hongwei Zhou, Sergey Kilin, Sergey Petkevich, Irina Kolesnik, Dominik L. Michels, Dmitry A. Lyakhov, Vladimir A. Kulchitsky
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Chemotherapy is one of the main treatment options for cancer, but it is usually accompanied with negative side effects. The classical drugs combination with synergistic adjuvants can be the solution to this problem, allowing reducing therape
Externí odkaz:
https://doaj.org/article/2fd4d0afd2a74e759c0abdc0b1a50ba5
Autor:
Jiaxue Liu, Xiaoli Bao, Irina Kolesnik, Boyan Jia, Zihan Yu, Caiyun Xing, Jiawen Huang, Tingting Gu, Xiaotong Shao, Alexey Kletskov, Andreii S. Kritchenkov, Vladimir Potkin, Wenliang Li
Publikováno v:
BIO Integration, Vol 3, Iss 3, Pp 103-111 (2022)
To increase the in vivo stability of cationic gene carriers and avoid the adverse effects of their positive charge, we synthesized a new shielding material by conjugating low molecular weight polyethylene glycol (PEG) to a hyaluronic acid (HA) core.
Externí odkaz:
https://doaj.org/article/3ea4883ce124478ebc1116bb7b168da3
Autor:
Aliaksandr Pushkarchuk, Tatsiana Bezyazychnaya, Vladimir Potkin, Evgenij Dikusar, Andrei Soldatov, Sergei Kilin, Alexander Nizovtsev, Semen Kuten, Dmitry Ermak, Vadim Pushkarchuk, Hongwei Zhou, Vladimir Kulchitsky
Publikováno v:
Journal of Biomedical Research & Environmental Sciences. 4:179-183
In the era of increasing the effectiveness of treatment methods and drugs used in modern neuro-oncology, the targeted delivery of diagnostic and medicinal substances to the tumor is of great importance. The aim of the work is to study in silico optim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7013fc51c073823fdcc31acdb5c6ba9c
https://doi.org/10.37871/jbres1661
https://doi.org/10.37871/jbres1661
Autor:
Vladimir Potkin, Aliaxandr Pushkarchuk, Alexandra Zamaro, Hongwei Zhou, Sergey Kilin, Sergey Petkevich, Iryna Kolesnik, Dominik Michels, Dmitry Lyakhov, Vladimir A. Kulchitsky
Chemotherapy is one of the main treatment options for cancer, but it is usually accompanied with negative side effects. The classical drugs combination with synergistic adjuvants can be the solution to this problem, allowing reducing therapeutic dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75bd0473c3482c6a6cbf30c8a75202fa
https://doi.org/10.21203/rs.3.rs-1358521/v1
https://doi.org/10.21203/rs.3.rs-1358521/v1
